Hira, T., Trakooncharoenvit, A., Taguchi, H., & Hara, H
By week four, I noticed my morning readings dropping into the low 100s consistently
For someone who wants a minimally invasive addition to their existing diet and exercise program, the risk-to-reward ratio is very low because the risks are essentially zero
In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
Retatrutide is a triple receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors
Serena Williams is opening up about her weight loss journey with GLP-1 medication Zepbound